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Abstract
Olfactory disorders are believed to affect 5% of the general population and have been shown to bear significant psychoso-
cial consequences to sufferers. Although more common than blindness and profound deafness in the United Kingdom, the 
impact of these disorders has not been assessed to date and the plight of British patients has yet to be quantified. In 2012, 
a patient support organization, Fifth Sense, was founded to provide information and support to sufferers of chemosensory 
disorders. Following a recent members conference, a survey of the membership was conducted anonymously using a series 
of questions based on an existing olfactory disorders questionnaire. From 496 respondents, this has demonstrated high rates 
of depression (43%) and anxiety (45%), impairment of eating experience (92%), isolation (57%), and relationship difficulties 
(54%). Women appear to have significantly more issues than men in terms of social and domestic dysfunction relating to 
olfactory loss (P = 0.01). Qualitative disorders also affected more than 1 in 5 members with parosmia reported in 19% and 
phantosmia in 24%. This paper discusses the details of the British story of anosmia and other related disorders as depicted 
by those most affected.
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Introduction
Hearing and visual loss are prominent sensory losses in 
the United Kingdom, both with their own Royal institu-
tions. More than 800 000 people in the United Kingdom 
are severely or profoundly deaf and about 2 million peo-
ple in the United Kingdom are living with sight loss. The 
prevalence of olfactory disorders in many national groups 
has been depicted in other studies with estimates varying 
between 1 and 20% (Wysocki and Gilbert 1989; Brämerson 
et al. 2004; Landis et al. 2004; Vennemann et al. 2008), with 
the larger figures representing older patient groups (Murphy 
et al. 2002). It is however believed from surveys done in other 
countries that 5% of the population is affected by anosmia, 
accounting for about 3 million people, with an additional 
15% affected by hyposmia (Mullol et  al. 2012), with some 
patients perhaps unaware of their reduced sensory capacity. 
Causes for olfactory loss are varied but the main diagnostic 
groups include sinonasal disease (such as chronic rhinosi-
nusitis and allergic rhinitis) (62%) and post-viral olfactory 
loss (PVOL) (11%) (Damm et al. 2004). In specialist smell 
and taste centers, other key groups of patients that are seen 
include post-traumatic olfactory loss and idiopathic cases, 
both of which account for about 20%, respectively, of the 
total volume of patients in those clinics. In the United 
Kingdom, a previous survey of consultant members of ENT 
United Kingdom showed that the management of olfac-
tory disorders in the United Kingdom was variable and few 
respondents (12%) routinely performed any formal assess-
ment of olfactory function (McNeill et al. 2007). Therefore, 
these patients have received limited evaluation and support 
in mainstream Ear Nose and Throat practice in the United 
Kingdom despite these patients being known to suffer sig-
nificant psychosocial consequences from the loss of this 
sensory modality (Hummel and Nordin 2005). This mostly 
stems from the lack of therapeutic options available to clini-
cians, that is, there is no clear clinical pathway as many doc-
tors believe the condition is untreatable.
In chronic rhinosinusitis, which has been estimated to 
affect 11% of Europeans (Hastan et  al. 2011), a reduced 
sense of smell is one of the diagnostic symptoms and yet in 
practice, reduction of this symptom appears to be deemed a 
lesser goal than other symptoms (Erskine et al. 2012). While 
sinonasal disease is considered a conductive and potentially 
reversible cause, there is currently no accepted effective and 
routine medical treatment for sensorineural causes, although 
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patients are sometimes offered a trial of oral corticosteroids. 
Some cases, such as PVOL, will resolve spontaneously with 
time in approximately 30% within 3–5 years; but otherwise 
these patients are left with a permanent sensory deficit. This 
sensory deficit is therefore borne by the sufferer without 
the absence of external signs, (e.g., stick, hearing aid), that 
are present with other sensory deficits. This study aims to 
characterize the consequences of olfactory disorders in the 
United Kingdom to help raise awareness of the plight of 
many sufferers.
Materials and methods
Members of the patient support organization, Fifth Sense 
(now a fledgling charity), were invited via e-mail by Mr Boak 
and asked to complete an online anonymous survey regard-
ing the quality of life impact of their disorders; membership 
is spread around the United Kingdom. No identifiable data 
was requested but the demographics of sex and age were 
recorded. The survey did not request any details about the 
cause of this disorder and the specific questions were derived 
from the olfactory disorders questionnaire produced by 
Frasnelli and Hummel (2005). The questions were adapted 
by the second author to be familiar to British patients and 
discernible. Domains included emotional, eating/nutrition, 
and psychiatric morbidity. The survey (see Appendix 1) had 
4 components:
1. 24 quality of life statements/questions to be ranked 
with one of the following options: Agree, Agree partly, 
Disagree partly, Disagree, I  think this question has no 
value, I don’t understand the question.
2. 7 questions requiring a yes or no answer to specifics 
about depression and anxiety.
3. 4 questions on impact rated on a scale of 0–10 where 
0 = no impact and 10 = large daily impact.
4. Free text entries relating to the above 4 questions or to 
anything not covered by the rest of the survey.
As the survey was performed out with the clinical domain 
using the membership of the support organization Fifth 
Sense, no ethical approval was sought; however, Mr Boak 
made explicit his intention for anonymized data to be used 
in the public domain. Differing rates of variables such as 
depression were compared between men and women using a 
chi-squared test. Differences in ratings using the 0–10 scale 
were compared between sexes using t-tests.
Results
From a membership of over 1000 sufferers with olfactory 
disorders, 496 completed the online survey during a 9-month 
period. The age range of respondents was 8–95 with a mean 
of 55 (parents responded on behalf  of the 8-year olds). The 
sex distribution was 178 men to 318 women meaning that two 
thirds of respondents were female. In the first section of the 
survey where members were asked rank the 24 statements/
questions, key subjects that elicited the response of “agreed” 
or “agreed partly” in more than 50% included (Figure 1):
•	 Reduced appreciation of food and drink (92%)
•	 Exposure to certain dangers (e.g., gas, rotten food) (85%)
•	 Emotional difficulties including anger, frustration, stress, 
and isolation (56–76%)
•	 “I go to restaurants less often than I used to” (55%)
•	 “My relationship with my partner/family/friends is 
affected by my difficulties with smelling” (54%)
In the second part of the survey where members were asked 
to provide a yes or no answer, the rate of depression was 43% 
with those suffering either depression and/or anxiety compris-
ing 45% of respondents (see Table 1); compared with a rate of 
depression in the adult population of 8–12%, this represents 
a significant burden (Singleton et al. 2003). Prescription of 
medications or use of NHS counseling services had occurred 
in 25% of respondents in relation to anxiety and depres-
sion resulting from their olfactory disorder. Furthermore, 
there are significantly higher rates of depression and anxi-
ety in female respondents (47% [n = 151] compared with 34% 
[n = 60] of men, P = 0.003). Twenty percent of members had 
tried various alternative medicine therapies including acu-
puncture, hypnotherapy, cranial osteopathy, and reflexology.
In the third part of the survey, members appeared to have 
noticed the greatest impact upon social and domestic life 
(Table 2), but with women again significantly more affected 
than men (social P = 0.028, domestic P < 0.001), even taking 
into consideration the higher number of female respondents. 
When these impact ratings were correlated against increas-
ing age, significant trends can be seen with all 4 factors 
(P < 0.001) such that younger sufferers are more likely to be 
adversely affected by these issues.
Looking in more detail at the specific impact of the qualita-
tive disorders, parosmia and phantosmia, shows some signif-
icant differences compared with those who do not experience 
these symptoms. In both categories of qualitative disorders, 
there is a significant difference from those without qualita-
tive disturbances for flavor perception eating unhealthily, 
eating less, despair, being less sociable, and stress (P ≤ 0.05). 
Phantosmia sufferers reported significantly higher rates of 
depression related to their olfactory disorder (P  =  0.008) 
than in those without (53 vs. 40%); parosmia sufferers did 
not show any significantly different rates of depression but 
instead a higher rate of anxiety (P = 0.007). Other notable 
findings are that younger aged sufferers (<50  years) show 
significantly higher rates of weight gain (P = 0.011), isola-
tion (P = 0.002), depression (P = 0.008), and being scared of 
dangers (P = 0.038); older sufferers showed higher rates of 
resignation to their sensory loss (P = 0.03).
In the free text components of the professional, social, 
domestic, and sexual issues, written entries were made by 
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185, 243, 288, and 130 members for those topics, respectively, 
and a number of key themes were identified as detailed with 
frequencies in Table  3. Professions most affected by smell 
disorders included those working in the food industry, the 
medical profession, childcare, and the housing and engineer-
ing industries. Many comments were made about respond-
ents’ concerns about personal hygiene at work and about 
difficulties with eating with colleagues. The latter also ran 
through into social circumstances, whereby many respond-
ents described annoyance at the lack of understanding by 
family and friends in social gatherings and hence avoidance 
of these situations. Other social and domestic issues encoun-
tered included birthdays, food preparation, for example, 
spoilt and burnt food, dinner parties, gas leaks, reliance 
on partners for their sense of smell, room/pet odors, body 
Figure 1 Quality of life questions—percentage of respondents agreeing or disagreeing (no response indicates that the member thought the question 
was invalid or did not understand it).
Table 1 Members responses for depression and anxiety in relation to 
their olfactory disorder




Depression or anxiety 52.4
Medications prescribed 13.5
Over-the-counter medications 14.1
Alternative medicine tried 19.5
Counseling for depression/anxiety 12.1
Table 2  Members responses for impact questions
Impact question Mean Median Standard 
deviation
Has your smell disorder had an impact 
on your professional life?
4.3 4 3.15
Has your smell disorder had an impact 
on your social life?
5.7 6 2.83
Has your smell disorder had an impact 
on your domestic life?
6.6 7 2.79
Has your smell disorder had an impact 
on your sex life?
3.9 3 3.07
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secretions smelling foul (parosmia sufferers), concern about 
personal hygiene, children, for example, nappies.
Among the other free text entries into the survey are a num-
ber of examples of key messages of impact to these sufferers.
Emotional
The key issue for me is one of frustration, and the future regarding 
my anosmia feels dismal. It’s difficult to quantify and I can see how 
some people might easily become depressed by it. It removes colour 
from a life.
I am devastated that I have not regained my sense of smell and upset 
that we’re expecting our first child and I won’t be able to smell them.
Life is totally unenjoyable. Is full of odours and tastes that make us 
aware of dangers and delight. This has been removed from me and 
my life. Something needs to be done to help us.
Input from the medical profession
One of the most depressing issues is the lack of concern by the medi-
cal profession. Getting help from GP and then being told by special-
ist that there was “nothing that could be done” and sent away to live 
the rest of your life missing one of your vital senses. If  I had lost my 
hearing, sight, a limb or had been disfigured more help would have 
been given. More training should be given on this issue for GPs and 
especially ENT students, with more smell and taste clinics provided.
I saw a consultant at my local clinic who said he’d never heard of the 
symptoms I have experienced over the last 20 years.
Even a specialist from a large teaching hospital could give me no 
hope of any form of self  or professional help I was just told it was 
something I had to live with
When I was told my anosmia was permanent, the doctor who told 
me became very embarrassed and possibly threatened by my reac-
tion and actually told me that I  should consider myself  lucky it 
wasn’t my sight. It’s over 9 years later and I am still very angry at 
the medical response.
Professional
It can be dangerous in the construction industry as unable to smell 
leaking gas etc
I am a chef and it has undermined my confidence in my ability to 
create new recipes
Working with children I am fearful that I cannot smell things of 
danger
I’m a psychiatric nurse …so I can’t tell if  somebody has been drink-
ing or if  they have tell-tale smells of certain conditions.
Isolation and danger
As a lone elderly man with few interactions other than with 
his family... Above all smell is the sense which makes reality 
different from a highly sophisticated TV facsimile. Its absence 
thereby gives a feeling of  isolation as well as depriving one of  a 
myriad of  pleasures, and, as I have personally experienced fol-
lowing a gas escape, can put one - and others - in very danger-
ous situations.
My house is rigged full of fire alarms and carbon monoxide alarms 
as I’m scared of not smelling fire.
I lost my sense of smell 34 years ago. I have still not come to terms 
with it. I remember what pleasure and learning I got through smell-
ing things. I used to be an avid cook and perfumes were a serious 
interest. Because it is an invisible disability, most people do not 
know I have it and do not understand.
Personal interaction and sex life
So much of sexual closeness is wrapped up in smell. It’s how you 
know who you are with when the lights are off. It has reduced my 
interest / desire.
Well many of us deal with it because there is no choice…and make the 
best of it...but it’s like seeing the world in monochrome and I worry 
I will never be able to share again properly in my social and sexual life. 
I feel like I’m just an observer.
Postoperative bliss
My sense of smell returned 5 days post-op and my life has since 
improved immeasurably. Every aspect of my life is happier having 
regained this very important sense.
Table 3 Free text themes in response to professional, social, domestic, and sexual issues (number in brackets = respondents entering comments)
Professional Social Domestic Sexual
Housing/engineering (5) Birthdays/family events (10) Lack of enjoyment of  
(preparation of) food (107)
Missing smelling partner (6)
Food industry (22) Dinner parties/eating out (160) Gas leaks, burnt/spoilt  
food, etc (133)
Loss of libido/desire (23)
Hazardous chemicals (27) Embarrassment (16) Reliance on partners for  
their sense of smell (45)
Concern about smelling appealing  
to the opposite sex (14)
Medical and allied  
professions (13)
Annoyance at lack of understanding 
by others (17)
Room/pet odors (63) Loss of intimacy (53)
Childcare/teaching (9) Concern about personal hygiene (30) Children, e.g., nappies (8) Cessation of dating/relationship (3)
“Do I smell at work?” (19) Loss of nice environmental odors (27) Personal hygiene/household  
smells (63)
Concern about not being able to  
detect sexually transmitted diseases (1)
Avoidance of eating with 
colleagues (9)
Relationship difficulties (9) Hobbies (4) Anxiety (2)
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Discussion
The findings of  this survey have clearly demonstrated that 
British sufferers of  olfactory disorders suffer significant 
physical, social, psychological, and emotional impacts. 
Fifth Sense, as a patient support organization, has clearly 
illuminated the largely unspoken voice of  these suffer-
ers through this survey, demonstrating the need for these 
conditions to be taken seriously by medical practition-
ers in the NHS as well as the need for more research into 
treatment and coping strategies for these patients. This 
paper is by no means the first to demonstrate these issues. 
Tafalla (2013) in her recent article on congenital anosmic 
has summarized many of  these issues from her own per-
spective and from those with and without smell disorders 
who she has consulted. A  more reaching perspective of 
the hidden consequences of  olfactory dysfunction was 
encapsulated by Keller and Malaspina (2013) who used 
an online study of  1000 subjects internationally including 
free-form reports and a questionnaire also adapted from 
that produced by Frasnelli and Hummel (2005). They 
similarly had two thirds of  respondents being female but 
primarily provided a qualitative analysis of  the reports 
returned. Hazard avoidance was discussed by 72% of  their 
respondents but lack of  food enjoyment (72%), weight 
loss/gain (25%), and the sense of  isolation (47%) were less 
prominent than in our British cohort, perhaps a reflec-
tion on cultural differences whereby British sufferers are 
more reserved in coming forwards with their problems. 
In exploring the issues of  social isolation, the authors 
also discussed the role of  medical practitioners managing 
these disorders, commenting that while most doctors han-
dle the discussions in a professional and empathic man-
ner, there are some doctors who have clearly not heard of 
anosmia, thus suggesting there is a bigger issue of  edu-
cating the medical profession; the quotations cited above 
were chosen to highlight the dismissive response given by 
a minority of  healthcare professionals. This problem with 
poor medical advice has been seen elsewhere. Landis et al. 
(2009) found that patients in their study reported receiv-
ing either no or poor information about their diagnosis 
and prognosis.
The frustration with medical professionals is certainly 
a key problem faced by many respondents in this survey, 
but judging by the responses in other areas clearly reflects 
a societal view of  the value of  olfaction in daily life, a 
subject broached more widely in the book Aroma: The 
Cultural History of Smell (Classen et al. 1994). Indeed a 
quick look at the NHS website for disability (http://www.
nhs.uk/livewell/disability/Pages/Disabilityhome.aspx) does 
not provide any mention of  olfactory disorders as a dis-
ability and examination of  the guidance as to what con-
stitutes a disability in the 2010 Equality Act (Anonymous 
2010) does not reveal any mention of  loss of  the ability to 
smell as a disability either. This is not solely confined to the 
United Kingdom, as the American Medical Association’s 
Guide to the Evaluation of  Permanent Impairment sug-
gests that smell loss is considered as a 1–5% impairment 
as compared with deafness (35%), blindness (85%), and 
even tinnitus (5%). American citizens do however have the 
advantage of  having a number of  well-established Smell 
& Taste Clinics such as that run by Prof. Richard Doty at 
the University of  Pennsylvania Smell and Taste Center in 
Philadelphia (Deems et al. 1991). Similarly, a number of 
European countries also have centers dedicated to these 
disorders, such as that run by Prof. Thomas Hummel in 
Dresden (Landis et al. 2004), but smell disorders are not 
mentioned on European Disability Forum website (http://
www.edf-feph.org/).
In other studies that have examined the quality of  life 
impacts of  olfactory disorders have also found similar 
themes. In 2002, Temmel et al. found that in most patients, 
olfactory loss caused food-related problems, younger 
patients had more complaints than older ones, and women 
had more complaints than men (Temmel et al. 2002), which 
has clearly been demonstrated in the Fifth Sense survey. 
In a Swedish study, sufferers attending one of  2 outpatient 
clinics were asked to state what the most negative effect of 
their disorders was; “less aware of  personal hygiene” was 
rated as the top complaint (36%) and being less interested 
in food and drink, second (21%) (Blomqvist et  al. 2004). 
In a study using the Becks Depression Inventory, it was 
reported that signs of  depression were found in 29% of 
patients with chemosensory disorders (Deems et al. 1991). 
In a Japanese study, Miwa et al. (2001) found, in their sub-
jects, that the most common cited impairments were abil-
ity to detect spoiled food (75%), gas leaks (61%), or smoke 
(50%), eating (53%), and cooking (49%). In Taiwan, Shu 
et al. (2011) found that the impact of  olfactory loss is more 
significantly felt by younger patients. Interestingly, the 
issue of  not recognizing hazardous odors in the elderly was 
reported back in 1957 by Chalke et al. (1958).
Overall, considering the domains explored by the Fifth 
Sense survey, previous studies have shown impact on these 
areas as shown in Table 4 (Ferris and Duffy 1989; Toller 1999; 
Miwa et al. 2001; Temmel et al. 2002; Blomqvist et al. 2004; 
Santos et  al. 2004; Brämerson et al. 2007; Aschenbrenner 
et al. 2008; Nordin et al. 2011; Croy et al. 2012; Haxel et al. 
2012; Keller and Malaspina 2013). The findings are gener-
ally that British subjects are more adversely affected than 
those in other countries. However, limitations of  the Fifth 
Sense Member Survey include a paucity of  detailed medi-
cal information such as diagnosis, duration, and etiology, 
as well as a reporting bias, as it is likely that those affected 
most by olfactory disorders will be Fifth Sense members 
and among the 496 respondents, therefore more likely to be 
proactive about their plight. Furthermore, the survey repre-
sents subjective opinion by those affected but on the other 
hand has the advantage of  providing information about the 
effects of  these disorders without the influence of  medical 
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professionals, as might be experienced in a formal study 
from a clinical setting.
Conclusion
This first survey of  British sufferers of  olfactory disor-
ders has revealed that there is a significant and previously 
unquantified problem with those affected in many ways 
from professional to emotional and nutritional issues. 
However, there is also a greater problem of  the under-
standing of  the role the sense of  smell plays in everyday 
lives, both in the general public and among the medical 
profession. Fifth Sense is moving toward charitable sta-
tus and will have, as its mission statement, the goals of 
improving treatment for patients, understanding of  the 
sense of  smell, and aiming to help generate more research 
into treatments for affected sufferers. It is hoped that this 
paper will highlight this neglected group of  patients and 
empower relevant clinicians to be more empathic in their 
dealings with them.
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What is your gender?
How do you feel about the following statements relating to 
your smell disorder?
 1. I often perceive a bad smell, regardless of whether a 
potential odor source is present
2. My biggest problem is not that odors are less intense (or 
absent), but that things smell different from the way they 
used to
3. I am aware of my problem all day long
4. It reduces my appreciation of food and drink
5. Food tastes different from what it used to
6. I now eat less than I used to
7. I now eat less healthily than I used to
8. I am now more careful about the food I eat
9. I have gained weight
10. I have lost weight
11. I go to restaurants less often than I used to
12. I am wondering if I will ever be able to live with this problem
13. I am more stressed than I used to be because of this problem
14. Sometimes I have thoughts and ideas I would not want 
other people to know of
15. Most of my problems are due to the difficulties with my 
sense of smell
16. I visit friends, relatives, or neighbors less often
17. I find it harder to relax
18. The difficulties with my sense of smell make me feel 
alone and isolated
19. I avoid groups of people
20. This problem is just one of the many problems in life 
one has to live with
21. I am scared of getting exposed to certain dangers (e.g., 
gas, rotten food)
22. I have problems taking part in many of the daily activi-
ties of life
23. The difficulties with smelling make me feel angry and/or 
frustrated
24. My relationship with my partner/family/friends is 
affected by my difficulties with smelling
Have you suffered from the following in relation to your 
smell disorder:
•	 Depression – Yes/No
•	 Anxiety – Yes/No
If you have suffered depression or anxiety as a result of your 
smell disorder, have you...
•	 Taken any medication prescribed by your GP (e.g., anti-
depressants, sedatives, anxiolytics)?
•	 Taken an over-the-counter medicine?
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•	 Taken an alternative medicine remedy?
•	 Received counseling?
•	 Other (please specify below)
Has your smell disorder had an impact on your professional 
life? (0–10 scale)
•	 Please provide details of any specific issues here
Has your smell disorder had an impact on your social life? 
(0–10 scale)
•	 Please provide details of any specific issues here
Has your smell disorder had an impact on your domestic 
life? (0–10 scale)
•	 Please provide details of any specific issues here
Has your smell disorder had an impact on your sex life? 
(0–10 scale)
•	 Please provide details of any specific issues here
Do you think there are any key issues that have not been 
covered by the above questions? If  so, please provide further 
details here.
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